(HALO) Halozyme Therapeutics - Performance 8.8% in 12m
HALO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
43.48%
#10 in Peer-Group
Rel. Strength
56.02%
#3371 in Stock-Universe
Total Return 12m
8.75%
#52 in Peer-Group
Total Return 5y
110.73%
#13 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 13.8 |
| P/E Forward | 11.0 |
| High / Low | USD |
|---|---|
| 52 Week High | 70.14 USD |
| 52 Week Low | 42.57 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 75.49 |
| Buy/Sell Signal +-5 | -0.79 |
| Support / Resistance | Levels |
|---|---|
| Support | 54.0, 52.0, 48.8, 45.6 |
| Resistance | 61.0, 57.8 |
12m Total Return: HALO (8.8%) vs XBI (-12.9%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-0.31% | 59.8% | 74.7% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
4.3% | -9.7% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.02% | -7.68% | 38% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.08% | 26.2% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.29% | -9.49% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.7% | 37.9% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.29% | 46.5% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
0.46% | 28.5% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: HALO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for HALO
| Total Return (including Dividends) | HALO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 5.87% | 4.10% | 4.77% |
| 3 Months | -6.91% | 13.70% | 16.02% |
| 12 Months | 8.75% | -12.86% | 12.44% |
| 5 Years | 110.73% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | HALO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 36.1% | 52.1% | 90.3% |
| 3 Months | -58.5% | 79.4% | 97.5% |
| 12 Months | 4.2% | -87.4% | 46.4% |
| 5 Years | 50.4% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th60.00 | 1.70% | 1.05% |
| 3 Month | %th19.50 | -18.13% | -19.76% |
| 12 Month | %th74.50 | 24.81% | -3.28% |
| 5 Years | %th95.00 | 170.02% | -0.94% |
FAQs
Does Halozyme Therapeutics (HALO) outperform the market?
Yes,
over the last 12 months HALO made 8.75%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.86%.
Over the last 3 months HALO made -6.91%, while XBI made 13.70%.
Performance Comparison HALO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
HALO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4.9% | 1.1% | -2.4% | -4% |
| US NASDAQ 100 | QQQ | 5% | 0.6% | -4.4% | -4% |
| German DAX 40 | DAX | 4.6% | 2.8% | -14.5% | -21% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.7% | 0.8% | -6.8% | -10% |
| Hongkong Hang Seng | HSI | 4% | 1.9% | -24.4% | -26% |
| India NIFTY 50 | INDA | 6.3% | 4.3% | -2.8% | 12% |
| Brasil Bovespa | EWZ | 9.1% | 6.2% | -17.4% | 8% |
HALO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.3% | 2.3% | -5.6% | -15% |
| Consumer Discretionary | XLY | 4% | 1.1% | 5.4% | -8% |
| Consumer Staples | XLP | 7% | 5.4% | -1.4% | 1% |
| Energy | XLE | 2% | 3.9% | 5.2% | 9% |
| Financial | XLF | 6.4% | 1.1% | -4.7% | -14% |
| Health Care | XLV | 4.8% | 6.1% | 9.2% | 16% |
| Industrial | XLI | 4.5% | 0.3% | -8.2% | -13% |
| Materials | XLB | 4.3% | 0.6% | -3% | 5% |
| Real Estate | XLRE | 5.2% | 5.7% | -0.8% | 2% |
| Technology | XLK | 5% | -1.3% | -7.5% | -1% |
| Utilities | XLU | 4.9% | 3.9% | -6.4% | -13% |
| Aerospace & Defense | XAR | 4.3% | -1.4% | -22.3% | -38% |
| Biotech | XBI | 1.3% | 1.8% | 7.9% | 22% |
| Homebuilder | XHB | 1.9% | -5.5% | 4.2% | 12% |
| Retail | XRT | 5% | -0.9% | 2.5% | 2% |
HALO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 4.3% | 9.52% | 11.6% | 12% |
| Natural Gas | UNG | 6.7% | 14.7% | 23.7% | 6% |
| Gold | GLD | 4.8% | 8.1% | -20.2% | -29% |
| Silver | SLV | 0.6% | -0.4% | -24.4% | -16% |
| Copper | CPER | -5.4% | -10.1% | -21.9% | -14% |
HALO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 5.8% | 6.1% | 3% | 12% |
| iShares High Yield Corp. Bond | HYG | 5.5% | 4.6% | 0.7% | -0% |